IRISS Medical awarded first patent in the US

November 27, 2014. London, UK – IRISS Medical Technologies, the Eye Data specialist, is pleased to announce that it has been awarded a US patent for a novel method for detecting strabismus (“squint”). Filed as US patent  8,882,269, the method described is used within the algorithms that power the Volk Eye Check device – a handheld diagnostic assistance tool for ophthalmologists and optometrists. The new method involves taking a digital photograph of the patient and analysing it in real time to determine whether strabismus is present. Current available methods rely on manual examinations performed by specialists. These require a high degree of skill and experience, especially with young children. This new automated method, deployed within the Volk Eye Check device, will complement and assist specialists’ manual examinations and will enable non-specialists to perform a strabismus test. Strabismus, with a prevalence of approximately 4% in children worldwide, is a chief cause of amblyopia (“lazy eye”), which is the leading cause of preventable blindness in people under the age of 40.